Protocol for a randomized controlled trial testing inhaled nitric oxide therapy in spontaneously breathing patients with COVID-19

Chong Lei, Binxiao Su, Hailong Dong, Bijan Safaee Fakhr, Luigi Giuseppe Grassi, Raffaele Di Fenza, Stefano Gianni, Riccardo Pinciroli, Emanuele Vassena, Caio Cesar Araujo Morais, Andrea Bellavia, Stefano Spina, Robert Kacmarek, Lorenzo Berra
doi: https://doi.org/10.1101/2020.03.10.20033522

Data Availability

This is a trial design for an upcoming study on COVID-19. We hypothesize that high concentrations of inhaled NO administered during early phases of COVID-19 infection can prevent the progression of the disease.

Back to top
Posted March 13, 2020.
Download PDF
Data/Code
Email
Protocol for a randomized controlled trial testing inhaled nitric oxide therapy in spontaneously breathing patients with COVID-19
Chong Lei, Binxiao Su, Hailong Dong, Bijan Safaee Fakhr, Luigi Giuseppe Grassi, Raffaele Di Fenza, Stefano Gianni, Riccardo Pinciroli, Emanuele Vassena, Caio Cesar Araujo Morais, Andrea Bellavia, Stefano Spina, Robert Kacmarek, Lorenzo Berra
medRxiv 2020.03.10.20033522; doi: https://doi.org/10.1101/2020.03.10.20033522
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area